Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-12 5:02 pm Unchanged |
2024-12-31 | 13G | Erasca, Inc. ERAS |
NOVARTIS INC | 12,307,692 4.400% |
0 (Unchanged) |
Filing History |
| 2025-02-12 5:00 pm Purchase |
2024-12-31 | 13G | Precision BioSciences, Inc. DTIL |
NOVARTIS INC | 413,581 5.400% |
413,581 (New Position) |
Filing History |
| 2024-05-08 4:01 pm Sale |
2024-03-31 | 13G | Poseida Therapeutics, Inc. PSTX |
NOVARTIS INC | 0 0.000% |
-5,908,089 (Position Closed) |
Filing History |
| 2023-05-26 4:17 pm Unchanged |
2023-05-10 | 13D | GAMIDA CELL LTD GMDAQ |
NOVARTIS INC | 4,336,759 4.100% |
0 (Unchanged) |
Filing History |
| 2023-03-03 4:02 pm Sale |
2022-12-30 | 13D | GAMIDA CELL LTD GMDAQ |
NOVARTIS INC | 4,336,759 5.800% |
-857,295 (-16.51%) |
Filing History |
| 2022-12-19 4:21 pm Purchase |
2022-12-09 | 13G | Erasca, Inc. ERAS |
NOVARTIS INC | 12,307,692 8.200% |
12,307,692 (New Position) |
Filing History |
| 2022-06-27 4:37 pm Purchase |
2022-06-15 | 13G | Precision BioSciences, Inc. DTIL |
NOVARTIS INC | 413,581 16.600% |
413,581 (New Position) |
Filing History |
| 2021-10-08 4:07 pm Purchase |
2021-09-01 | 13G | SomaLogic, Inc. SLGC |
NOVARTIS INC | 10,367,340 5.700% |
10,367,340 (New Position) |
Filing History |
| 2021-03-11 4:35 pm Unchanged |
2021-03-01 | 13D | GAMIDA CELL LTD GMDAQ |
NOVARTIS INC | 5,194,054 8.800% |
0 (Unchanged) |
Filing History |
| 2021-02-23 7:57 pm Sale |
2021-02-19 | 13D | CELLULAR BIOMEDICINE GROUP, IN CBMG |
NOVARTIS INC | 0 0.000% |
-1,458,257 (Position Closed) |
Filing History |
| 2021-02-16 4:10 pm Purchase |
2020-12-31 | 13G | BioLineRx Ltd. BLRX |
NOVARTIS INC | 125,000 1.000% |
116,667 (+1400.00%) |
Filing History |
| 2021-02-12 4:24 pm Purchase |
2020-12-31 | 13G | Poseida Therapeutics, Inc. PSTX |
NOVARTIS INC | 5,908,089 9.600% |
5,908,089 (New Position) |
Filing History |
| 2020-08-14 4:49 pm Purchase |
2019-06-28 | 13D | GAMIDA CELL LTD GMDAQ |
NOVARTIS INC | 5,194,054 10.300% |
1,919 (+0.04%) |
Filing History |
| 2020-08-14 4:32 pm Unchanged |
2020-08-11 | 13D | CELLULAR BIOMEDICINE GROUP, IN CBMG |
NOVARTIS INC | 1,458,257 7.500% |
0 (Unchanged) |
Filing History |